United Therapeutics Corp

NASDAQ:UTHR  
198.08
+4.31 (+2.22%)
Mergers / Acquisitions

United Therapeutics Announces Agreement To Acquire Priority Review Voucher

Published: 12/28/2020 11:11 GMT
United Therapeutics Corp (UTHR) - United Therapeutics Announces Agreement to Acquire Priority Review Voucher.
United Therapeutics Corp - Deal for $105 Million.
United Therapeutics Corp - Voucher Expected to Be Applied to Forthcoming NDA for Tyvaso Dpi.
United Therapeutics Corp - Intends to Apply Prv to Its NDA for Tyvaso Dpi, Expected in First Half of 2021.